FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug label

Nat Biotechnol. 2017 Jul 12;35(7):606. doi: 10.1038/nbt0717-606.
No abstract available

MeSH terms

  • Aminophenols / therapeutic use*
  • Cystic Fibrosis / drug therapy*
  • Drug Approval*
  • Drug Labeling
  • Humans
  • Quinolones / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Aminophenols
  • Quinolones
  • ivacaftor